Old Web
English
Sign In
Acemap
>
authorDetail
>
Lukas Semmler
Lukas Semmler
Charité
Medicine
Internal medicine
Canakinumab
Endocrinology
Reactive oxygen species
4
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
The effect of canakinumab on COVID19-associated cardiomyocyte contractile dysfunction and arrhythmias
2021
European Heart Journal
S Dimai
Lukas Semmler
Harald Stachelscheid
B. Pieske
Frank R. Heinzel
Felix Hohendanner
Show All
Source
Cite
Save
Citations (0)
Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.
2021
International Journal of Molecular Sciences
David Bode
Lukas Semmler
Christian U. Oeing
Alessio Alogna
Gabriele G Schiattarella
Burkert Pieske
Frank R. Heinzel
Felix Hohendanner
Show All
Source
Cite
Save
Citations (0)
Dual SGLT-1 and SGLT-2 inhibition improves left atrial dysfunction in HFpEF
2021
Cardiovascular Diabetology
David Bode
Lukas Semmler
Paulina Wakula
Niklas Hegemann
Uwe Primessnig
Nicola Beindorff
David R. Powell
Raphael Dahmen
Hartmut Ruetten
Christian Oeing
Alessio Alogna
Daniel Messroghli
Burkert Pieske
Frank R. Heinzel
Felix Hohendanner
Show All
Source
Cite
Save
Citations (10)
COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
2021
PLOS ONE
Sanzio Dimai
Lukas Semmler
Ashok Prabhu
Harald Stachelscheid
Judith Huettemeister
Sandra C Klaucke
Philipp Lacour
Florian Blaschke
Jan Kruse
Abdul Shokor Parwani
Leif-Hendrik Boldt
Lars Bullinger
Burkert Pieske
Frank R. Heinzel
Felix Hohendanner
Show All
Source
Cite
Save
Citations (1)
1